2010 Scientific Meeting of the National Antimicrobial Resistance Monitoring System; Public Meeting; Request for Comments, 16817 [2010-7496]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 63 / Friday, April 2, 2010 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2010–N–0001]
2010 Scientific Meeting of the National
Antimicrobial Resistance Monitoring
System; Public Meeting; Request for
Comments
AGENCY:
Food and Drug Administration,
HHS.
mstockstill on DSKH9S0YB1PROD with NOTICES
ACTION: Notice of public meeting;
request for comments.
The Food and Drug Administration
(FDA) is announcing a public meeting
entitled ‘‘2010 Scientific Meeting of the
National Antimicrobial Resistance
Monitoring System.’’ The topic to be
discussed is the results from the
National Antimicrobial Resistance
Monitoring System (NARMS) and
related antimicrobial resistance
monitoring and research, including
activities in other national programs.
Date and Time: The public meeting
will be held on July 15 and 16, 2010,
from 8 a.m. to 5 p.m.
Location: The public meeting will be
held at Hyatt Regency-Atlanta hotel, 265
Peachtree St. NE, Atlanta, GA 30303,
404–577–1234, FAX: 404–588–4137.
Contact Person: Joanne Kla, Center for
Veterinary Medicine (HFV–12), Food
and Drug Administration, 7519 Standish
Pl., Rockville, MD 20857, 240–276–
9129, e-mail: NARMSinternational
Meeting@fda.hhs.gov, FAX: 240–276–
9115.
Registration and Requests for Oral
Presentations: Send registration
information (including name, title, firm
name, address, telephone and fax
number, and e-mail address), and
written material and requests to make
oral presentations, to the contact person
(see Contact Person) on or before July 7,
2010. There is no registration fee for the
public meeting. Early registration is
recommended because seating is
limited. Registration on the day of the
public meeting will be provided on a
space available basis beginning at 8 a.m.
on the day of the meeting.
If you need special accommodations
due to a disability, please contact the
Hyatt Regency-Atlanta hotel, (see
Location) at least 7 days in advance.
Interested persons may present data,
information, or views, orally or in
writing, on the topic of the discussion
of the meeting. Written submissions
may be made to the contact person on
or before July 1, 2010, for distribution at
the meeting. Oral presentations from the
public during the open public comment
period will be scheduled between
VerDate Nov<24>2008
16:40 Apr 01, 2010
Jkt 220001
approximately 4 p.m. and 5 p.m. on July
16, 2010. Those desiring to make oral
presentations should notify the contact
person by July 1, 2010, and submit a
brief statement of the general nature of
information they wish to present and an
indication of the approximate time
requested to make their presentation.
Time allotted for each presentation may
be limited. The contact person will
inform each speaker of their schedule
prior to the meeting.
Comments: Regardless of attendance
at the public meeting, interested persons
may submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852. Submit electronic comments
to https://www.regulations.gov. Submit a
single copy of electronic comments or
two paper copies of any mailed
comments, except that individuals may
submit one paper copy. Comments are
to be identified with the docket number
found in brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday. The docket
will remain open for written or
electronic comments for 30 days
following the meeting.
Agenda: The meeting will address
goals and challenges of monitoring
antimicrobial susceptibility in
foodborne bacteria, and present research
on the microbiology and epidemiology
of resistance. The agenda for the public
meeting will be made available on the
agency’s Web site at https://
www.fda.gov/AnimalVeterinary/
SafetyHealth/AntimicrobialResistance/
NationalAntimicrobialResistance
MonitoringSystem/ucm059135.htm.
Transcripts: FDA will prepare a
meeting transcript and make it available
on the agency’s Web site (see Agenda)
after the meeting. FDA anticipates that
transcripts will be available
approximately 30 business days after
the meeting. The transcript will be
available for public examination at the
Division of Dockets Management (HFA–
305), 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852, between 9 a.m.
and 4 p.m., Monday through Friday. A
transcript will also be available in either
hardcopy or on CD–ROM, after
submission of a Freedom of Information
request. Written requests are to be sent
to Division of Freedom of Information
(HFI–35), Office of Management
Programs, Food and Drug
Administration, 5600 Fishers Lane, rm.
6–30, Rockville, MD 20857.
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
16817
Dated: March 30, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–7496 Filed 4–1–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Meeting for Software Developers on
the Technical Specifications for
Common Formats for Patient Safety
Data Collection and Event Reporting
AGENCY: Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION:
Notice of public meeting.
SUMMARY: This notice announces a
meeting to discuss the technical
specifications for AHRQ’s common
definitions and reporting formats
(Common Formats) Version 1.1 that
allow for reporting of patient safety
information to Patient Safety
Organizations (PSOs). The Patient
Safety and Quality Improvement Act of
2005, 42 U.S.C. 299b–21 to b–26,
(Patient Safety Act) provides for the
formation of PSOs, which collect,
aggregate, and analyze confidential
information regarding the quality and
safety of healthcare delivery. The
Patient Safety Act (at 42 U.S.C. 299b–
23) authorizes the collection of this
information in a standardized manner,
as explained in the related Patient
Safety and Quality Improvement Final
Rule, 42 CFR part 3 (Patient Safety
Rule), published in the Federal Register
on November 21, 2008: 73 FR 70731–
70814. As authorized by the Secretary of
HHS, AHRQ coordinates the
development of the Common Formats
that allow healthcare providers to
voluntarily collect and submit
standardized information regarding
patient safety events. More information
on the Common Formats Version 1.1,
including the technical specifications,
can be obtained through AHRQ’s PSO
Web site: https://www.PSO.AHRQ.gov/
index.html.
Technical specifications promote
standardization by ensuring that data
collected by PSOs and other entities are
clinically and electronically
comparable. This meeting is designed as
an interactive forum where PSOs and
software developers can provide input
on these technical specifications for the
Common Formats Version 1.1. AHRQ
especially requests input from those
entities which have implemented, or
E:\FR\FM\02APN1.SGM
02APN1
]]>Agencies
[Federal Register Volume 75, Number 63 (Friday, April 2, 2010)]
[Notices]
[Page 16817]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-7496]
[[Page 16817]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2010-N-0001]
2010 Scientific Meeting of the National Antimicrobial Resistance
Monitoring System; Public Meeting; Request for Comments
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting; request for comments.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing a public
meeting entitled ``2010 Scientific Meeting of the National
Antimicrobial Resistance Monitoring System.'' The topic to be discussed
is the results from the National Antimicrobial Resistance Monitoring
System (NARMS) and related antimicrobial resistance monitoring and
research, including activities in other national programs.
Date and Time: The public meeting will be held on July 15 and 16,
2010, from 8 a.m. to 5 p.m.
Location: The public meeting will be held at Hyatt Regency-Atlanta
hotel, 265 Peachtree St. NE, Atlanta, GA 30303, 404-577-1234, FAX: 404-
588-4137.
Contact Person: Joanne Kla, Center for Veterinary Medicine (HFV-
12), Food and Drug Administration, 7519 Standish Pl., Rockville, MD
20857, 240-276-9129, e-mail: NARMSinternationalMeeting@fda.hhs.gov,
FAX: 240-276-9115.
Registration and Requests for Oral Presentations: Send registration
information (including name, title, firm name, address, telephone and
fax number, and e-mail address), and written material and requests to
make oral presentations, to the contact person (see Contact Person) on
or before July 7, 2010. There is no registration fee for the public
meeting. Early registration is recommended because seating is limited.
Registration on the day of the public meeting will be provided on a
space available basis beginning at 8 a.m. on the day of the meeting.
If you need special accommodations due to a disability, please
contact the Hyatt Regency-Atlanta hotel, (see Location) at least 7 days
in advance.
Interested persons may present data, information, or views, orally
or in writing, on the topic of the discussion of the meeting. Written
submissions may be made to the contact person on or before July 1,
2010, for distribution at the meeting. Oral presentations from the
public during the open public comment period will be scheduled between
approximately 4 p.m. and 5 p.m. on July 16, 2010. Those desiring to
make oral presentations should notify the contact person by July 1,
2010, and submit a brief statement of the general nature of information
they wish to present and an indication of the approximate time
requested to make their presentation. Time allotted for each
presentation may be limited. The contact person will inform each
speaker of their schedule prior to the meeting.
Comments: Regardless of attendance at the public meeting,
interested persons may submit written comments to the Division of
Dockets Management (HFA-305), Food and Drug Administration, 5630
Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments
to https://www.regulations.gov. Submit a single copy of electronic
comments or two paper copies of any mailed comments, except that
individuals may submit one paper copy. Comments are to be identified
with the docket number found in brackets in the heading of this
document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday. The docket
will remain open for written or electronic comments for 30 days
following the meeting.
Agenda: The meeting will address goals and challenges of monitoring
antimicrobial susceptibility in foodborne bacteria, and present
research on the microbiology and epidemiology of resistance. The agenda
for the public meeting will be made available on the agency's Web site
at https://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/ucm059135.htm.
Transcripts: FDA will prepare a meeting transcript and make it
available on the agency's Web site (see Agenda) after the meeting. FDA
anticipates that transcripts will be available approximately 30
business days after the meeting. The transcript will be available for
public examination at the Division of Dockets Management (HFA-305),
5630 Fishers Lane, rm. 1061, Rockville, MD 20852, between 9 a.m. and 4
p.m., Monday through Friday. A transcript will also be available in
either hardcopy or on CD-ROM, after submission of a Freedom of
Information request. Written requests are to be sent to Division of
Freedom of Information (HFI-35), Office of Management Programs, Food
and Drug Administration, 5600 Fishers Lane, rm. 6-30, Rockville, MD
20857.
Dated: March 30, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-7496 Filed 4-1-10; 8:45 am]
BILLING CODE 4160-01-S
